JP Morgan has once again selected Boston Scientific (NYSE: BSX) and intuitive surgical (NASDAQ: ISRG) as its top MedTech picks for the new year and reaffirmed insulin pump maker Insulet (NASDAQ: PODD) as the primary choice of SMID cap.
Generally, JPM analyst